Odyssey Health Reports Worsening Financials, Going Concern Warning, and Key Agreement Termination
ODYY sits 48% above its 52-week low of $0.005.
Summary
Odyssey Health reported a worsening financial position with a significant working capital deficit, a 'going concern' warning, and the termination of a key product agreement, despite a non-cash quarterly profit.
Key Events · Earnings and Guidance · ODYY
-
Going Concern Warning Reiterated
The company continues to express substantial doubt about its ability to continue as a going concern due to an operating deficit and a working capital deficit of $9.75 million as of April 30, 2026, which is approximately 14 times its market capitalization.
-
Worsening Financial Position
Net loss for the nine months ended April 30, 2026, widened to $(3.32) million from $(1.49) million in the prior year. Operating cash burn increased to $(886,778) from $(299,193) year-over-year.
-
Reliance on Dilutive Financing
The company incurred $3.08 million in financing costs and recognized a new derivative liability of $2.43 million, primarily from convertible notes and warrants issued to Mast Hill Fund L.P. This indicates heavy reliance on complex and potentially dilutive financing to sustain operations.
-
Key Product Agreement Terminated
The exclusive global sub-license agreement for the BreastCheck device was immediately cancelled on May 6, 2026, due to a breach by the licensor, NeuRX Health, Inc. This follows an 8-K filing on May 11, 2026.
Analysis · ODYY · Industrial Applications And Services
Odyssey Health's latest quarterly report highlights severe financial distress, with a reiterated 'going concern' warning and a substantial working capital deficit that is approximately 14 times its current market capitalization. The company's net loss for the nine-month period significantly widened, and it continues to rely heavily on dilutive financing, incurring millions in financing costs and derivative liabilities. The cancellation of the exclusive BreastCheck sub-license agreement further compounds the challenges for this development-stage company with no revenue. While the company reported a net income for the quarter, this was primarily due to a non-cash gain from derivative liability fair value changes, masking underlying operational losses and cash burn.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ODYY was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $679K. The 52-week trading range was $0.00 to $0.13. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.